Sung PH, Chiang HJ, Li YC, Chiang JY, Chu CH, Shao PL, Lee FY, Lee MS, Yip HK. Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy. Stem Cell Res Ther. 2020 Jul 29;11(1):324.
Sung PH, Fu M, Chiang HJ, Huang CR, Chu CH, Lee MS, Yip HK. Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases. Biomed J. 2021 Dec;44(6 Suppl 2):S201-S209.
Sung PH, Chai HT, Yang CC, Chiang JY, Chen CH, Chen YL, Yip HK. Combined levosimendan and Sacubitril/ Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat. Biomed Pharmacother. 2022 Feb 21;148:112745.2. Sung PH, Fu M, Chiang HJ, Huang CR, Chu CH, Lee MS, Yip HK. Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases. Biomed J. 2021 Dec;44(6
